Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: J Adolesc. 2022 Nov 28;95(3):427–436. doi: 10.1002/jad.12125

TABLE 2.

Model results

OCS age 17 Cannabis age 17 OCS age 19 Cannabis age 19
Overall sample (N = 547)
 OCS PRS −0.02 −0.12** 0.08* −0.04
 OCS age 17 - 0.18*** 0.32*** −0.03
 Cannabis age 17 - - 0.13** 0.53***
 OCS age 19 - - - 0.03
European American males (n = 120)
 OCS PRS 0.01 −0.20* 0.07 −0.15+
 OCS age 17 - 0.20* 0.30** −0.03
 Cannabis age 17 - - 0.15 0.43***
 OCS age 19 - - - −0.03
European American females (n = 118)
 OCS PRS −0.07 −0.16+ 0.12 0.00
 OCS age 17 - 0.32** 0.18+ −0.08
 Cannabis age 17 - - 0.16 0.52***
 OCS age 19 - - - 0.03
African American males (n = 76)
 OCS PRS −0.09 0.10 0.09 0.05
 OCS age 17 - 0.04 0.30** −0.01
 Cannabis age 17 - - 0.26* 0.69***
 OCS age 19 - - - −0.04
African American females (n = 96)
 OCS PRS −0.19+ −0.06 −0.01 0.03
 OCS age 17 - 0.26* 0.43*** 0.05
 Cannabis age 17 - - 0.04 0.57***
 OCS age 19 - - - 0.15

Abbreviations: OCS, obsessive-compulsive symptoms; PRS, polygenic risk scores.

***

p < .001;

**

p < .01;

*

p < .05.

+

p < .1.